When Should Progression Lead to Treatment Changes? – 2022 Program: Targeted Therapies Forum

Understanding when to adjust cancer treatment is paramount in patient care. In this crucial session, Drs. Desai, Khalil, and Luo shed light on the indicators, strategies, and considerations that guide the decision to change treatment during cancer progression.

Supported by our committed sponsors #Novartis, #Janssen, #Blueprintmedicine, #TakedaOncology, #Astrazeneca, #LillyOncology, and #genentech, this video offers essential insights for patients, caregivers, and healthcare professionals.

For further guidance, resources, and community support, please visit cancerGRACE.org. To engage with experts and peers on this vital subject, join the conversation at https://cancergrace.org/forum.